What is the total return of PMCB over the past year?
PharmaCyte Biotech, Inc. (PMCB) delivered a return of -42.20% over the past year. Since PMCB does not currently pay dividends, the total return equals the price-only return.
PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc. did not pay dividends during this period.
Total return equals price-only return for non-dividend stocks.
PharmaCyte Biotech, Inc. (PMCB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For these stocks, total return equals price appreciation.
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform. The calculation accounts for the compounding effect where reinvested dividends generate their own future dividends.
PharmaCyte Biotech, Inc. (PMCB) delivered a return of -42.20% over the past year. Since PMCB does not currently pay dividends, the total return equals the price-only return.
A $10,000 investment in PharmaCyte Biotech, Inc. one year ago would be worth $5,780 today, representing a loss of $4,220.
PharmaCyte Biotech, Inc. (PMCB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
Screen for dividend stocks with the highest total returns (including DRIP). See which dividend stocks actually grow your wealth.
Calculate total returns for related stocks: